Labcorp
802 hedge funds and large institutions have $15.1B invested in Labcorp in 2019 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 257 increasing their positions, 275 reducing their positions, and 37 closing their positions.
275% more call options, than puts
Call options by funds: $148M | Put options by funds: $39.4M
211% more first-time investments, than exits
New positions opened: 115 | Existing positions closed: 37
9% more funds holding
Funds holding: 738 → 802 (+64)
1% more capital invested
Capital invested by funds: $14.9B → $15.1B (+$196M)
0.9% more ownership
Funds ownership: 106.12% → 107.02% (+0.9%)
7% less repeat investments, than reductions
Existing positions increased: 257 | Existing positions reduced: 275
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$63.8M |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
+$60.4M |
| 3 |
Lazard Asset Management
New York
|
+$57.3M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$39.7M |
| 5 |
Two Sigma Advisers
New York
|
+$35.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Melvin Capital Management
New York
|
-$91.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$78.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$49.3M |
| 4 |
Millennium Management
New York
|
-$47.9M |
| 5 |
SL
Summitry LLC
Foster City,
California
|
-$44.7M |
LH Hedge Fund Activity: Q4 2019 in Review
802 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q4 2019, worth a combined $15.1B — up 1.3% from $14.9B a quarter earlier.
Buyers outnumbered sellers: 115 funds opened new LH positions and 37 closed out — a net gain of 78 holders — while 257 added to existing stakes and 275 trimmed.
The largest buyer was HealthCor Management, adding an estimated $63.8M. The largest seller was Melvin Capital Management, cutting an estimated $91.6M.
- 802 institutional investors held Labcorp (LH) as of Q4 2019, up from 738 in Q3 2019.
- Funds reported $15.1B of Labcorp stock for Q4 2019, up 1.3% quarter-over-quarter.
- 115 funds opened new Labcorp positions in Q4 2019 and 37 closed out, a net change of +78 holders.
- The largest Labcorp buyer in Q4 2019 was HealthCor Management, an estimated $63.8M added.
- The largest Labcorp seller in Q4 2019 was Melvin Capital Management, an estimated $91.6M sold.
Based on aggregated 13F filings for Q4 2019.